Luveltamab is a humanized anti-FOLR1 monoclonal antibody, primarily utilized as the targeting component of the ADC Luveltamab tazevibulin. This research tool is applied in leukemia studies, supporting both in vitro cell-based assays and in vivo preclinical research to investigate targeted therapeutic strategies.
Konzentration:
6.25 mg/mL
Molekulargewicht:
146.09 kDa
Reinheit:
97.70% (May vary between batches)
Target-Kategorie:
Antifolate
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten